Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daruka Mahadevan

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|August 14, 2012
Novel targeted therapies and combinations for the treatment of multiple myelomaAmit Agarwal, Daruka Mahadevan
Expert Opinion on Investigational Drugs|April 13, 2016
Programming the immune checkpoint to treat hematologic malignanciesEric Vick, Daruka Mahadevan
Current Cancer Drug Targets|September 24, 2005
Strategies for targeting the multidrug resistance-1 (MDR1)/P-gp transporter in human malignanciesDaruka Mahadevan, Nikhil Shirahatti
Expert Opinion on Drug Discovery|March 15, 2013
Aurora kinase targeted therapeutics in oncology: past, present and futureDaruka Mahadevan, Sunni Beeck
Expert Reviews in Molecular Medicine|November 19, 2009
Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?Sreenivasa Chandana, Daruka Mahadevan
Clinical Cancer Drugs|September 6, 2016
Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human MalignanciesBenny Johnson, Daruka Mahadevan
Future Oncology (London, England)|April 24, 2014
Monoclonal antibodies as therapeutics in human malignanciesManjari Pandey, Daruka Mahadevan
Expert Review of Anticancer Therapy|September 28, 2018
A comprehensive review of protein kinase inhibitors for cancer therapyRadhamani Kannaiyan, Daruka Mahadevan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Novel therapeutics for aggressive non-Hodgkin's lymphomaDaruka Mahadevan, Richard I Fisher
Trends in Cancer|April 16, 2020
Janus Face of Drug-Induced Tetraploidy in Non-Hodgkin LymphomaDaruka Mahadevan, Gregory C Rogers
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Cardiovascular & Hematological Disorders Drug Targets|August 14, 2012
Novel targeted therapies and combinations for the treatment of multiple myelomaAmit Agarwal, Daruka Mahadevan
Expert Opinion on Investigational Drugs|April 13, 2016
Programming the immune checkpoint to treat hematologic malignanciesEric Vick, Daruka Mahadevan
Current Cancer Drug Targets|September 24, 2005
Strategies for targeting the multidrug resistance-1 (MDR1)/P-gp transporter in human malignanciesDaruka Mahadevan, Nikhil Shirahatti
Expert Opinion on Drug Discovery|March 15, 2013
Aurora kinase targeted therapeutics in oncology: past, present and futureDaruka Mahadevan, Sunni Beeck
Expert Reviews in Molecular Medicine|November 19, 2009
Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?Sreenivasa Chandana, Daruka Mahadevan
Clinical Cancer Drugs|September 6, 2016
Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human MalignanciesBenny Johnson, Daruka Mahadevan
Future Oncology (London, England)|April 24, 2014
Monoclonal antibodies as therapeutics in human malignanciesManjari Pandey, Daruka Mahadevan
Expert Review of Anticancer Therapy|September 28, 2018
A comprehensive review of protein kinase inhibitors for cancer therapyRadhamani Kannaiyan, Daruka Mahadevan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Novel therapeutics for aggressive non-Hodgkin's lymphomaDaruka Mahadevan, Richard I Fisher
Trends in Cancer|April 16, 2020
Janus Face of Drug-Induced Tetraploidy in Non-Hodgkin LymphomaDaruka Mahadevan, Gregory C Rogers
Pageof 13